Lincoln Pharma shares slip as Q2 profit drops 24%, margins under pressure
Published on 13/11/2025 01:15 PM
Lincoln Pharma shares slip as Q2 profit drops 24%, margins under pressureLincoln Pharma's revenue marginally rose by 1.4% to ₹163.4 crore from ₹161.2 crore in the base quarter.By CNBCTV18.com November 13, 2025, 1:15:26 PM IST (Published)1 Min Read(Photo Credit : CNBC-TV18 Library )Shares of Lincoln Pharmaceuticals Ltd. are trading lower on Thursday, November 13, after the company reported a decline in profit and operating performance for the September quarter.
The drugmaker's net profit fell 24% year-on-year to ₹20 crore, compared to ₹26 crore in the same period last year.
Revenue marginally rose by 1.4% to ₹163.4 crore from ₹161.2 crore in the base quarter.
EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) declined 10.2% to ₹25.4 crore, while the EBITDA margin slipped to 15.5% from 17.6% last year.
Lincoln Pharma shares are now trading 2.05% lower at ₹518.95. The stock is down 40% so far in 2025.Continue ReadingCheck out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!Tags